Amakuru

Ibisubizo by'ingenzi by'ubuvuzi bwa CD7-Targeted CAR-T kuri T-ALL na T-LBL
Ubushakashatsi buherutse gukorwa bwerekana umusaruro mwiza wo kuvura CD7-targeted chimeric antigen receptor (CAR) T cells mu kuvura abarwayi ba T-cell acute lymphoblastic leukemia (T-ALL) na T-cell lymphoblastic lymphoma (T-LBL) bafite.

Ibyatangajwe ku nama ngarukamwaka ya ASH yo mu 2024 n'imurikagurisha
Inama ngarukamwaka ya 66 y’Umuryango w’Abanyamerika w’Ubuvuzi bw’Amaraso (ASH) izaba kuva ku ya 7 kugeza ku ya 10 Ukuboza 2024, ibera mu Kigo cy’Amakoraniro cya San Diego, igaragaza ubushakashatsi bugezweho n’iterambere mu bijyanye n’amaraso.

Gutangaza Inama Ngarukamwaka ya Lu Daopei Hematology ya 2024 muri Kanama
Inama ngarukamwaka ya 12 ya Lu Daopei Hematology iteganyijwe kuba ku ya 23-24 Kanama 2024, mu Kigo Mpuzamahanga cy’Amateraniro cya Beijing. Twifatanye natwe mu biganiro birambuye ndetse n’iterambere rigezweho mu bijyanye n’amaraso.

Ibyiringiro Bishya mu Kuvura Kanseri: Ubuvuzi bwa TILs Buragaragara nk'Umupaka Ukurikira
Nubwo hari imbogamizi zikomeje mu iterambere ry’inganda n’ubucuruzi, imbogamizi za CAR-T therapy ziri gukemurwa n’uburyo bushya butanga icyizere: Uburyo bwo kuvura kanseri y’ibibyimba (TIL). Ubu buryo bugaragaza igihe gishya mu kurwanya ibibyimba bikomeye.
Ese uburyo bwo kuvura uturemangingo ni bwo hazaza h’indwara ziterwa n’ubwiyongere bw’umubiri?
Uburyo bushya bwo kuvura kanseri bushobora kandi kuvura no gusubiza ubudahangarwa bw'umubiri kugira ngo butange ihumure ry'igihe kirekire cyangwa ndetse bunakize indwara zimwe na zimwe ziterwa n'ubwiyongere bw'umubiri.

Gufungura ASH mu 2023 | Dr. Peihua Lu atanga CAR-T ku bushakashatsi bwa AML bwo gusubira inyuma / bwo kutumvikana

ASH 2023 | "Ijwi rya Lu Daopei" iririmba ku rubyiniro mpuzamahanga











